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Abstract
We isolated and characterized CHO mutants deficient in peroxisome assembly using green fluorescent protein (GFP) and
blue fluorescent protein (BFP) as the fluorescent probes to study the molecular mechanism of peroxisome biogenesis. We
used stable transformants of CHO cells expressing GFP appending peroxisome targeting signal-1 (PTS1) and/or peroxisome
targeting signal-2 (PTS2) as the parent strains for rapid isolation of the mutants. We have obtained six peroxisome-deficient
mutants by visual screening of the mislocalizations of the peroxisomal GFPs. Mutual cell fusion experiments indicated that
the six mutants isolated were divided into four complementation groups. Several of the mutants obtained possessed defective
genes: the PEX2 gene was defective in SK24 and PT54; the PEX5 gene in SK32 and the PEX7 gene in PT13 and PT32. BE41,
which belonged to the fourth complementation group, was not determined. When peroxisomal forms of BFP were transiently
expressed in mutant cells, the peroxisomal BFPs appending both PTS1 and PTS2 appeared to bypass either the PTS1 or
PTS2 pathway for localization in SK32. This observation suggested that other important machinery, in addition to the PTS1
or PTS2 pathway, could be involved in peroxisome biogenesis. Thus, our approach using peroxisomal fluorescent proteins
could facilitate the isolation and analysis of peroxisome-deficient CHO mutants and benefit studies on the identification and
role of the genes responsible for peroxisome biogenesis. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
Peroxisomes are ubiquitous organelles in various
eukaryotes from yeast to humans. The organelles
are involved in many metabolic pathways including
hydrogen peroxide-based cellular respiration, L-oxi-
dation of fatty acids and biosynthesis of plasmalo-
gen. Thus, the organelles are necessary for cellular
metabolism and required for normal human develop-
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ment. Human peroxisome-de¢cient disorders result
in genetically heterogeneous diseases including lethal
Zellweger syndrome, neonatal adrenoleukodystrophy
and infantile Refsum disease [1]. Cell fusion studies
between ¢broblasts from patients have clari¢ed at
least 13 di¡erent complementation groups [2,3].
CHO cells have been widely used as mammalian cells
and the isolation of peroxisome-de¢cient mutants de-
rived from CHO cells has greatly aided our under-
standing of primary defects of human peroxisome-
de¢cient disorders and the molecular mechanism of
peroxisome biogenesis [4^7].
In order to achieve rapid isolation of peroxisome-
de¢cient mammalian cell mutants, a visual screening
procedure was developed using the peroxisomal
forms of green £uorescent protein (GFP). Since the
£uorescent signal from GFP can be observed in liv-
ing cells, it has been used for visualizing the intra-
cellular movement of proteins [8,9]. Two types of
peroxisome targeting signals (PTS) have been identi-
¢ed, PTS1 and PTS2. PTS1 consists of a C-terminal
tripeptide SerLysLeu (SKL) motif and has been
found in many peroxisomal proteins [10]. PTS2 con-
sists of an N-terminal extension sequence and has
been found in a few matrix proteins [11]. Since
both PTS1 and PTS2 appear to be involved in direct-
ing various proteins to the peroxisomal matrix, the
peroxisomal form of GFP appending PTS (PTS-
GFP) could be targeting peroxisomes. Ghaedi et al.
recently reported peroxisome-de¢cient mutants from
stable transformants expressing GFP-PTS1 or PTS2-
GFP [12]. In this study, we used as the parental
strains three types of stable transformants in-
volving wild-type CHO cells expressing peroxisomal
GFP appending both PTSs and then isolated six per-
oxisome-de¢cient mutants by a visual screening of
the mislocalization of GFP with a combination of
9-(1P-pyrene)nonanol (P9OH)/ultraviolet (UV) irradi-
ation methods [13]. Six mutants, which were divided
into four complementation groups, exhibited charac-
teristic mislocalization of the peroxisomal blue £uo-
rescent proteins when mutants were transfected with
cDNAs encoding for the BFPs. Mutants belonging
to three of the four complementation groups were
found to be defective in PEX2, PEX5 and PEX7
genes. In particular, SK32, defective in the PEX5
gene, showed an interesting intracellular localization
of the peroxisomal BFPs suggesting the involvement
of other import machinery in addition to the PTS1
and PTS2 pathways. BE41 exhibited similar mislo-
calization of the peroxisomal BFPs, as did PT13 and
PT32 defective in the PEX7 gene, but was found to
belong to the fourth complementation group distinct
from the other three. We did not determine the gene
responsible for the mutant phenotype in BE41. Thus,
we show here that the £uorescent protein probes are
available for isolation and characterization of peroxi-
some-de¢cient CHO mutants.
2. Materials and methods
2.1. Stable transformant of CHO cell expressing the
peroxisomal GFP (PTS-GFP)
CHO cells were cultured in Dulbecco’s modi¢ed
Eagle’s medium supplemented with 10% fetal calf
serum. Wild-type CHO-K1 cells were transfected
with plasmid encoding for each form of peroxisomal
GFP, GFP-PTS1, PTS2-GFP or PTS2-GFP-PTS1
and then selected in medium containing 0.4 mg/ml
hygromycin B. The transfection of plasmid was car-
ried out by a liposome-mediated procedure using
lipofectamine, as described in the manufacturer’s in-
structions (Gibco BRL).
2.2. Construction of peroxisomal GFP
The peroxisomal forms of GFP were produced
using Pfu polymerase (Toyobo) from EGFP (Clon-
tech) as a template by polymerase chain reaction
(PCR). The conditions were as follows: 2 min at
95‡C for initial heating, 25 cycles of 95‡C for 1 min,
65‡C for 1.5 min, one cycle of 72‡C for 10 min. GFP-
PTS1 was created by appending oligonucleotide en-
coding for the SKL sequence immediately upstream
of the stop codon. PSTS2-GFP was created by ap-
pending the oligonucleotide encoding for a 14 amino
acid sequence in the N-terminal extension region of
rat 3-ketoacyl-CoA thiolase [11] immediately down-
stream of the initiation codon. PTS2-GFP-PTS1 ap-
pending the amino-terminal extension sequence and
the carboxy-terminal SKL motif was also similarly
created by PCR. The DNA fragment encoding for
the peroxisomal GFP was constructed into a eukary-
otic expression vector pcDEBN under the control of
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SRK promoter, conferring resistance to hygromycin
B [14].
2.3. Isolation of peroxisome-de¢cient mutant
Each parent cell expressing peroxisomal GFP was
inoculated at 1U105 cells/dish and cultured over-
night. Cells were then mutagenized with 0.4 mg/ml
ethyl methanesulfonate (EMS) for 18 h, washed
twice with growth medium and cultured for a further
2 days. Cells were then exposed to P9OH treat-
ment and long wave UV light irradiation, as de-
scribed [13]. P9OH/UV-resistant colonies appeared
in 7^10 days, at which time a single colony was se-
lected from each dish to be assured of having an
independent mutant colony. Cells from each colony
were divided into two dishes and the intracellular
localization of the peroxisomal GFP was observed
in one dish to examine the peroxisome-de¢ciency.
Peroxisome-de¢cient mutant clones were cultured in
the other dishes.
2.4. Complementation analysis by cell fusion
Mutant cells were fused with a derivative of wild-
type CHO-K1, resistant to ouabain (Ouar) by a poly-
ethylene-glycol-mediated cell fusion procedure [15].
Fused cells were selected in medium containing 0.4
mg/ml hygromycin B and 0.5 mM ouabain to exam-
ine whether the mutant phenotype for the localiza-
tion of GFP was restored with the wild-type gene.
Mutual complementation experiments between iso-
lated mutants were carried out using derivatives of
each mutant, which were doubly resistant to 8-aza-
guanine (AGr) and ouabain (Ouar). Hybrid cells
were selected in HAT medium containing 0.5 mM
ouabain to examine whether restorations on peroxi-
some assembly were observed. The restoration was
determined by the relocalization of the mislocalized
peroxisomal GFP. Thus, the isolated mutants were
divided into complementation groups. Complemen-
tation tests with human ¢broblasts from peroxisome
biogenesis disorder (PBD) patients were examined by
restoration of peroxisomes using immunocytochemi-
cal staining of catalase in fused cells, as described
[16]. SK32 AGr was fused with the ¢broblast and
selected with HAT selection medium containing hy-
gromycin B.
2.5. Construction of peroxisomal BFP
The peroxisomal forms of BFP were produced
using KOD polymerase (Toyobo) from pQBI50
(Takara) as a template by PCR. Three forms of per-
oxisomal BFP appending the same extension sequen-
ce(s) as PTS-GFP were created and are hereafter
referred to as BFP-PTS1, PTS2-BFP and PTS2-
BFP-PTS1, respectively. The DNA fragment encod-
ing for the peroxisomal BFP was constructed into a
eukaryotic expression vector pcDEBN (neo), which
was a derivative of pcDEBN, conferring resistance
to G-418 in place of hygromycin B and was provided
by Dr. Y. Nakabeppu (Kyushu University).
2.6. Construction of plasmid encoding for PEX cDNA
Rat PEX2 cDNA was created by PCR, which was
carried out by using sense primer (5P-CCGCAA-
GCTTGATATGGCTGCCAGAGAAGAGAGTA-
CACAA-3P), antisense primer (5P-CCGCAAGCTT-
GGTTTCTAAAGAGCATTCACTTCTGACATT-
3P), KOD polymerase and rat liver cDNA (Clontech)
as the template. The conditions were as follows: 30 s
at 98‡C for initial heating, then 30 cycles of 98‡C for
15 s, 60‡C for 30 s and 74‡C for 30 s, followed by
one cycle of 74‡C for 3 min. The PCR product was
digested with HindIII and subcloned into pBluescript
SK(+) to verify the nucleotide sequence. The Hin-
dIII^BamHI fragment containing rat PEX2 cDNA
was then subcloned into pcDEBN(neo). Human
PEX5 cDNA and mouse PEX7 cDNA were pre-
pared as described [17].
2.7. Plasmid transfection and morphological analysis
The transfection was carried out by a liposome-
mediated procedure using lipofectamine as described.
The peroxisomal form of GFP expressed stably was
observed under a £uorescent microscope (Zeiss Axio
plan) with a No. 10 ¢lter. The peroxisomal form of
BFP expressed transiently was observed 48 h after
the transfection, under a £uorescent microscope
with a No. 18 ¢lter. Peroxisomes were also observed
by indirect immunocytochemical staining, using rab-
bit antibody against rat catalase and rhodamine-la-
beled swine anti-rabbit immunoglobulin (DAKO)
under a £uorescent microscope with a No. 15 ¢lter.
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3. Results
3.1. Isolation of peroxisome-de¢cient CHO mutants
and mutual complementation analysis
We tried to establish three types of stable trans-
formants of CHO cells expressing the recombinant
GFP targeted to peroxisome in order to easily isolate
numerous peroxisome-de¢cient mutants. Wild-type
CHO-K1 cells were transfected with plasmid encod-
ing for each form of peroxisomal GFP (GFP-PTS1,
PTS2-GFP or PTS2-GFP-PTS1) and stable trans-
formants were selected in growth medium with hy-
gromycin B. Three colonies were selected from each
type and examined for the peroxisomal localization
of the GFP. The peroxisomal targeting was veri¢ed
by the observation that the GFP was localized in
punctate structures, as was catalase (Fig. 1a,b).
Thus, CHOPS1a expressing GFP-PTS1, CHOPS2a
expressing PTS2-GFP and CHOPS12a expressing
PTS2-GFP-PTS1, which exhibited peroxisomal local-
ization of the GFP, were established and used as the
parental strains for isolating peroxisome-de¢cient
mutants.
Parent cells were mutagenized with EMS and sub-
jected to P9OH/UV selection. P9OH is an analogue
of fatty alcohol and incorporated into cellular com-
ponents at a step of plasmalogen biosynthesis. Expo-
sure of long wave UV generates reactive oxygen from
P9OH and caused cell death. Because plasmalogen
Fig. 1. Mislocalization of peroxisomal GFP in mutant cells. (a) Wild-type CHOPS1a, £uorescence of GFP-PTS1; (b) wild-type
CHOPS1a, £uorescence of catalase immunostained; (c) mutant SK24, £uorescence of GFP-PTS1; (d) mutant SK24, £uorescence of
catalase; (e) mutant SK32, £uorescence of GFP-PTS1; (f) mutant PT13, £uorescence of PTS2-GFP; (g) mutant PT13, £uorescence of
catalase immunostained; (h) mutant PT32, £uorescence of PTS2-GFP; (i) mutant PT54, £uorescence of PTS2-GFP; (j) mutant BE41,
£uorescence of PTS2-GFP-PTS1.
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biosynthesis occurs in peroxisomes, peroxisome-de¢-
cient mutant cells could be enriched by P9OH/UV
treatment [13]. Thus, six independent mutants have
been isolated. Two mutants (SK24 and SK32) were
isolated from parent cell CHOPS1a, three mutants
(PT13, PT32 and PT54) from parent cell CHOPS2a
and one mutant (BE41) from parent cell CHOPS12a.
These mutants exhibited cytosolic mislocalization of
the GFP expressed (Fig. 1c,e,f,h,i,j). When the intra-
cellular localization of endogenous peroxisomal pro-
tein, catalase, was examined to con¢rm the de¢cien-
cies of peroxisome biogenesis in the mutant cells,
three mutants SK24 (Fig. 1d), SK32 and PT54
showed the cytosolic distributions of catalase, but
the other mutants, PT13 (Fig. 1g), PT32 and BE41
showed localization in punctate structures, as did
wild-type CHO cell (data not shown on SK32,
PT54, PT32 and BE41). These di¡erent phenotypes
suggested that the defects in mutant cells could be
caused by some distinct genes responsible for peroxi-
some biogenesis.
Cell fusion experiments with wild-type CHO indi-
cated that all mutant phenotypes for the mislocaliza-
tion of peroxisomal GFP were restored with wild-
type gene and, therefore, recessive (Table 1A). Mu-
tual complementation experiments were then done to
divide the mutants into complementation groups.
The peroxisome-de¢cient mutant was fused with
double resistant cells (AGr and Ouar) derived from
the other mutants and examined to determine
whether the mislocalizations of the GFP were re-
stored in hybrid cells. Peroxisome assembly was re-
Fig. 2. Complementation analysis by cell fusion between mutant CHO cells. Hybrid cells between (a) PT13AGrOuar and SK32, (b)
SK32AGrOuar and PT13 and (c) PT13AGrOuar and PT32 were selected in HAT medium containing 0.5 mM ouabain and 0.4 mg/ml
hygromycin B and then examined for the restoration of £uorescent GFP.
Table 1
Mutual complementation analysis between CHO mutant cells
Mutant (A) (B) (C) (D) (E)
CHO-Ouar SK24AGrOuar SK32AGrOuar PT13AGrOuar BE41AGrOuar
SK24 + ND + + +
SK32 + + ND + +
PT13 + + + ND +
PT32 + + + 3 +
PT54 + 3 + + +
BE41 + + + + ND
(A) Peroxisome-de¢cient CHO mutants were fused with a derivative of wild-type CHO resistant to ouabain. Hybrid cells were selected
in medium containing 0.5 mM ouabain and 0.4 mg/ml hygromycin B. Restoration of peroxisome assembly was observed in all mu-
tants (+). (B) SK24AGrOuar, (C) SK32AGrOuar, (D) PT13AGrOuar or (E) BE41AGrOuar were fused with other mutants. Hybrid
cells were selected in HAT medium containing 0.5 mM ouabain and 0.4 mg/ml hygromycin B. Restoration of peroxisome assembly
was (+) or was not (3) observed. ND: experiment was not done. The peroxisomal forms of GFP were used to assay rescue of protein
import.
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stored in SK24 fused with SK32, PT13, PT32 or
BE41, but not with PT54. Peroxisome assembly in
PT13 fused with SK24, SK32, PT54 or BE41 was
restored, but not with PT32. Peroxisome assembly
of both SK32 and BE41 was restored when fused
with any of the other mutants (Table 1B^D). Fig. 2
shows the restorations on peroxisome assembly in
hybrid cells between SK32 and PT13, or no restora-
Fig. 3. Intracellular localization of peroxisomal BFP in mutant cells. The £uorescent BFP was observed in mutant cells transfected
with cDNA encoding for BFP-PTS1 (i), PTS2-BFP (ii) or PTS2-BFP-PTS1 (iii). Mutant SK24 (a), PT54 (b), SK32 (c), PT13 (d),
PT32 (e) and BE41 (f) were transfected and observed as described in Section 2.
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tion between PT13 and PT32. In summary, the ex-
periments indicated that the six mutants isolated
were divided into four complementation groups, as
follows: SK24 and PT54 (¢rst group); SK32 (second
group); PT13 and PT32 (third group) and BE41
(fourth group) (Table 1).
3.2. Characterization of mutants using BFP
appending PTS(s)
We characterized the mutants, which were divided
into four complementation groups, using peroxisom-
al forms of BFP as the £uorescent probes. The £uo-
Fig. 4. Complementation analysis by cDNA transfection. (a) SK24, no infection; (b) SK24 transfected with rat PEX2 cDNA;
(c) SK32, no infection; (d) and (e) SK32 transfected with human PEX5 cDNA; (f) PT13, no infection; (g) PT13 transfected with
mouse PEX7 cDNA. Fluorescent GFP was examined in (a), (b), (f) and (g). The punctate £uorescent structures in (b) and (g) were
colocalized with immunostained catalase (data not shown). Immunocytochemical staining with anti-rat catalase was examined in (c)
and (d). Faint signals of cytosolic catalase in SK32 were emphasized in (c). Immunocytochemical staining with anti-PTS1 antibody
was done in (e) as described [22].
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rescent BFP was observable in cells expressing GFP
because BFP emits a £uorescent spectrum distinct
from GFP. Three forms of peroxisomal BFP ap-
pending PTS1 and/or PTS2 were produced by
PCR, similarly to the peroxisomal GFPs, and con-
structed into a eukaryotic expression vector as de-
scribed in Section 2. Mutant cells were transfected
with cDNA encoding for peroxisomal BFP and in-
tracellular localizations of the BFPs were observed.
Mutants, SK24 and PT54, which belonged to the
¢rst complementation group, showed cytosolic distri-
butions of all three forms of peroxisomal BFP (Fig.
3a,b). Mutants SK32, which belonged to the second
group, exhibited an interesting localization of the
peroxisomal BFPs, cytosolic distribution in BFP-
PTS1 or PTS2-BFP appending either PTS, but per-
oxisomal localization in PTS2-BFP-PTS1, appending
both PTSs (Fig. 3c). Mutants PT13 and PT32, which
belonged to the third group, had the intracellular
localizations of peroxisomal BFPs expected for mu-
tants defective in a function of PTS2 receptor, cyto-
solic distribution of PTS2-BFP, but peroxisomal lo-
calizations of BFP-PTS1 and PTS2-BFP-PTS1 (Fig.
3d,e). Mutant BE41, which belonged to a comple-
mentation group distinct from the other ¢ve mu-
tants, exhibited similar localizations of peroxisomal
BFPs to PT13 and PT32, speci¢cally, cytosolic dis-
tribution of PTS2-BFP, but peroxisomal localiza-
tions of BFP-PTS1 and PTS2-BFP-PTS1 (Fig. 3f).
The characterizations of the transient expression of
peroxisomal BFPs were veri¢ed by the observations
that endogenous peroxisomal proteins, catalase
(PTS1 type) and 3-ketoacyl-CoA thiolase (PTS2
type) were localized on immunocytochemical staining
in most mutants except for SK32 (see Section 4),
similarly to the peroxisomal BFPs (data not shown).
Thus, the six mutants exhibited characteristic pheno-
types of the intracellular localizations of peroxisomal
BFPs, according to the complementation group.
3.3. Complementation analysis with cDNA
transfection or human PBD patient ¢broblasts
Our classi¢cation of the peroxisome-de¢cient mu-
tants with peroxisomal GFPs and BFPs as £uores-
cent probes was developed by complementation anal-
ysis using transfection of cDNA encoding PEX gene
or cell fusion with human PBD patient ¢broblasts.
When PEX2 cDNA was transfected in mutants, it
restored peroxisome assembly of SK24 (Fig. 4a,b)
and PT54 (data not shown), belonging to the ¢rst
complementation group, but not that of SK32,
PT13, PT32 or BE41 (data not shown). These obser-
vations indicated that SK24 and PT54 were defective
in the PEX2 gene. Cell fusion analyses with human
PBD ¢broblasts were then carried out on SK32, be-
longing to the second complementation group. Per-
oxisome assembly of SK32 was restored in hybrid
cells with ¢broblasts from 10 of 11 complementation
groups examined, but not from complementation
group 2 (Table 2 and Fig. 5). The cell fusion experi-
ments suggested that the de¢ciency of SK32 be-
longed to human complementation group 2. Group
2 is a de¢ciency in the PEX5 gene encoding for the
PTS1 receptor [18]. SK32 was then transfected with
PEX5 cDNA and it was found that peroxisome as-
sembly was restored (Fig. 4c^e). These results indi-
cated that SK32 was defective in the PEX5 gene and
that a functional loss of the PTS1 receptor caused
the de¢ciency in peroxisome assembly in SK32.
Then, the observation of peroxisomal BFPs sug-
gested that PT13 might be defective in the PEX7
gene encoding for the PTS2 receptor (Fig. 3d). A
transfection experiment with PEX7 cDNA resulted
in restorations of peroxisome assembly in PT13
(Fig. 4f,g) and PT32 (data not shown). Taken togeth-
er, these results indicated that the peroxisome de¢-
ciencies in PT13 and PT32 were due to a functional
loss of the PTS2 receptor (Table 1D and Figs. 2c and
4f,g). Cell fusion analysis with human ¢broblasts has
not been carried out on BE41, because the mutant
appears to show peroxisomal localization on cata-
Table 2
Complementation analysis by cell fusion between SK32 and hu-
man ¢broblasts
Complementation group of human PBD patient
¢broblasts
A B C E F G H J 2 3 6
SK32 + + + + + + + + 3 + +
SK32AGrOuar mutant cells were fused with ¢broblasts derived
from PBD patients belonging to each of the 11 complemen-
tation groups indicated. The restoration (+) of peroxisome as-
sembly or no restoration (3) was examined by immunocyto-
chemical staining with anti-rat catalase antibody. Human
complementation groups are described in [3].
BBAMCR 14609 5-4-00
M. Ito et al. / Biochimica et Biophysica Acta 1496 (2000) 232^242 239
lase, as does the wild-type cell (data not shown).
Therefore, the gene responsible for the de¢ciency of
peroxisome assembly remains to be determined for
BE41.
4. Discussion
The peroxisome-de¢cient CHO mutants have pro-
vided useful tools to study the roles and functions of
molecular components involved in peroxisome bio-
genesis [19]. Here we showed a rapid procedure for
isolating and analyzing peroxisome-de¢cient mutants
using peroxisomal forms of £uorescent proteins. Six
mutants, which exhibited cytoplasmic localizations of
the peroxisomal GFPs, have been obtained. Mutual
cell fusion analyses indicated that the six mutants
isolated were divided into four complementation
groups. The mutants, belonging to each complemen-
tation group showed characteristic phenotypes with
regard to the intracellular localizations of the peroxi-
somal BFPs, respectively, when mutants were trans-
fected with cDNAs encoding for the BFPs (Fig. 3).
SK24 and PT54 exhibited cytosolic localizations of
three forms of peroxisomal BFPs (BFP-PTS1, PTS2-
BFP and PTS2-BFP-PTS1) (Fig. 3a,b). The mutant
phenotypes in SK24 and PT54 were found to be due
to the functional loss of the PEX2 protein (Table 1B
and Fig. 4a,b). Since Tsukamoto et al. showed that
mutants defective in the PEX2 gene exhibited mislo-
calizations of catalase (PTS1 type) and 3-ketoacyl-
CoA thiolase (PTS2 type) [5], it was determined
that the analyses with peroxisomal BFPs could accu-
rately re£ect the intracellular localizations of the en-
dogenous peroxisomal proteins. In fact, immunocy-
tochemical stainings showed the cytoplasmic
localizations of catalase and 3-ketoacyl-CoA thiolase
in SK24 and PT54 (Fig. 1d for catalase in SK24, but
data not shown on others).
SK32 exhibited an interesting phenotype, the cyto-
plasmic distribution of BFPs appending either PTS
(BFP-PTS1 or PTS2-BFP), but peroxisomal localiza-
tion of PTS2-BFP-PTS1 appending both PTSs (Fig.
3c). The cell fusion analysis and transfection experi-
ment indicated that SK32 was defective in the PEX5
gene encoding for PTS1 receptor (Table 2 and Figs.
4c^e and 5). It seems that the PTS1 and PTS2 path-
ways are fully distinct in yeast [20,21]. Nevertheless,
the cytosolic distribution on BFP appending either
PTS could be plausible in SK32, since the function
of the PTS1 receptor was recently reported to be
required not only for the import of PTS1 proteins
but also that of PTS2 proteins in mammalian cells,
suggesting that the PTS1 receptor could mediate the
import of PTS2 proteins bound with the PTS2 recep-
tor [22,23]. The peroxisomal localization on the BFP
appending both PTSs suggests that peroxisomal pro-
teins carrying both PTS1 and PTS2 could overcome
the defective import pathway caused by the dysfunc-
tion of PTS1 receptor. When endogenous peroxisom-
al proteins were examined in SK32 mutant cells, cat-
alase appeared to be localized in cytoplasm but 3-
ketoacyl-CoA thiolase did in peroxisomes (data not
shown). Thus, further mutational analysis in SK32
will provide information on peroxisome biogenesis.
PT13 and PT32, which are defective in the PEX7
Fig. 5. Immunocytochemical analysis in hybrid cells between
SK32 and human PBD patient ¢broblasts. Fused cells of SK32
with human PBD patient group E (a) or 2 (b) were examined
for immunocytochemical staining with anti-rat catalase anti-
body. Punctate structures were observed in (a) but not in (b).
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gene encoding for the PTS2 receptor (Table 1D and
Fig. 4f,g), exhibited the localizations expected on the
peroxisomal BFPs, cytosolic distribution on PTS2-
BFP, but peroxisomal localizations in BFP-PTS1
and PTS2-BFP-PTS1 (Fig. 3d,e). The observations
obtained here for the PEX mutants indicate that
the peroxisomal BFPs could represent excellent £uo-
rescent probes for studying peroxisome biogenesis.
Mutual complementation analysis indicated that
BE41 belonged to a fourth group distinct from
PT13 and PT32 (Table 1D,E). However, BE41 ex-
hibited localizations on the peroxisomal BFPs similar
to those of PT13 and PT32 (Fig. 3d^f), suggesting
that the de¢ciency in BE41 might be due to a func-
tional loss of some component involved in the PTS2-
import pathway. When BE41 was examined on en-
dogenous peroxisomal proteins with immunocyto-
chemical staining, catalase was localized in the per-
oxisomes, but 3-ketoacyl-CoA thiolase appeared to
have leaked into the cytoplasm (data not shown).
This immunocytochemical observation suggested a
functional loss of the PTS2-import pathway in
BE41. Since it has been reported that some peroxi-
somal proteins encoded by PEX18 and PEX21 genes
are responsible for the PTS2 receptor-mediated im-
port pathway [24], BE41 might be defective in a gene
responsible for the PTS2-import pathway but not in
the PEX7 gene. On the function of the gene defective
in BE41, the mutant phenotype is suggestive. The
BE41 mutant, which was isolated originally by the
inability to import PTS2-GFP-PTS1, can properly
localize PTS2-BFP-PTS1 in peroxisome (Figs. 1j
and 3f). Since the BFP is produced transiently by
transfection of the cDNA in BE41, a stable trans-
formant on the GFP, it might be that peroxisomes
can take in a smaller amount of the BFP but not a
large quantity of the GFP. Then, further study re-
mains to be done on BE41. Thus, the peroxisomal
£uorescent proteins were found to be useful in the
isolation and analysis of peroxisomal-de¢cient CHO
mutants and our approach will facilitate determina-
tion of the genes responsible for peroxisome biogen-
esis and clari¢cation of the functional roles of the
products.
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